BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 35236731)

  • 1. Pharmacist's time spent: Space for Pharmacy-based Interventions and Consultation TimE (SPICE)-an observational time and motion study.
    Karia A; Norman R; Robinson S; Lehnbom E; Laba TL; Durakovic I; Balane C; Joshi R; Webster R
    BMJ Open; 2022 Mar; 12(3):e055597. PubMed ID: 35236731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol.
    Karia AM; Balane C; Norman R; Robinson S; Lehnbom E; Durakovic I; Laba TL; Joshi R; Webster R
    Int J Pharm Pract; 2020 Oct; 28(5):441-448. PubMed ID: 32347607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considering pharmacy workflow in the context of Australian community pharmacy: A pilot time and motion study.
    Cavaye D; Lehnbom EC; Laba TL; El-Boustani E; Joshi R; Webster R
    Res Social Adm Pharm; 2018 Dec; 14(12):1157-1162. PubMed ID: 29317188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
    Winslade N; Tamblyn R
    BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of patients' requests and pharmacists' professional practice in oropharyngeal condition in Spain.
    Hernández A; Garcia-Delgado P; Garcia-Cardenas V; Ocaña A; Labrador E; Orera ML; Martinez-Martinez F
    Int J Clin Pharm; 2015 Apr; 37(2):300-9. PubMed ID: 25708123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective.
    Sim TF; Wright B; Hattingh L; Parsons R; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):511-521. PubMed ID: 31300355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumer perspectives about weight management services in a community pharmacy setting in NSW, Australia.
    Um IS; Armour C; Krass I; Gill T; Chaar BB
    Health Expect; 2014 Aug; 17(4):579-92. PubMed ID: 22646843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative exploration of mental health services provided in community pharmacies.
    Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA
    PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
    Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
    Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national survey of pharmacists and interns in Aotearoa New Zealand: provision and views of extended services in community pharmacies.
    McDonald J; Morris C; Pledger M; Dunn P; Fa'asalele Tanuvasa A; Smiler K; Cumming J
    BMC Health Serv Res; 2021 Oct; 21(1):1147. PubMed ID: 34688303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knee osteoarthritis and the knowledgeable, trustworthy pharmacist: Patient and pharmacist perceptions of community pharmacy-based education and support.
    Darlow B; Brown M; Hudson B; Frew G; Clark J; Vincent L; Grainger R; Marra C; McKinlay E; Abbott JH; Briggs AM
    Musculoskeletal Care; 2023 Mar; 21(1):3-15. PubMed ID: 35615979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rural pharmacists and stakeholders perspectives of expanded pharmacy practice: A descriptive study.
    Taylor SM; Cairns A; Glass BD
    Aust J Rural Health; 2021 Jun; 29(3):341-353. PubMed ID: 34148266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.